Recent U.S. Food and Drug Administration (FDA) Decision Upsets Careful Balance Struck by Congress in Dietary Supplement Health and Education Act (DSHEA)

Congress struck a careful balance between providing consumers with access to safe dietary supplements and maintaining strict safety and efficacy standards for drugs when it enacted DSHEA in 1994. A recent decision by FDA concerning the regulatory status of nicotinamide mononucleotide (NMN) upsets the careful balance struck by Congress in DSHEA. Because FDA’s abrupt and […]